These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 262009)

  • 1. [Side-effects of azathioprine and cyclophosphamide therapy].
    Grgić Z
    Neurologija; 1979; 27(1-4):201-4. PubMed ID: 262009
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies.
    Lin PT; Martin BA; Weinacker AB; So YT
    Muscle Nerve; 2006 Mar; 33(3):433-5. PubMed ID: 16116645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive drug therapy in myasthenia gravis.
    Niakan E; Harati Y; Rolak LA
    Arch Neurol; 1986 Feb; 43(2):155-6. PubMed ID: 3947257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
    Cosi V; Lombardi M; Erbetta A; Piccolo G
    Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive therapy of various autoimmune diseases of the nervous system].
    Neretin VIa; Odinokova VA; Kir'iakov VA; Sapfirova VA
    Sov Med; 1990; (12):31-5. PubMed ID: 2097756
    [No Abstract]   [Full Text] [Related]  

  • 6. Azathioprine in the treatment of myasthenia gravis.
    Witte AS; Cornblath DR; Parry GJ; Lisak RP; Schatz NJ
    Ann Neurol; 1984 Jun; 15(6):602-5. PubMed ID: 6742794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine experience in severe, generalized, recalcitrant myasthenia gravis.
    Kornfeld P; Ambinder EP; Matta R; Bender A; Papatestas AE; Gross H; Genkins G
    Mt Sinai J Med; 1985 May; 52(5):347-52. PubMed ID: 3874354
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fluocortolon, azathioprine and cyclophosphamide in the therapy of myasthenia gravis].
    Jusić A; Zagar M
    Neurologija; 1979; 27(1-4):167-79. PubMed ID: 400406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comments on the indication of immunosuppressive long-term therapy in myasthenia gravis (author's transl)].
    Fasshauer K; Rath I
    Fortschr Neurol Psychiatr; 1981 Mar; 49(3):109-12. PubMed ID: 7227961
    [No Abstract]   [Full Text] [Related]  

  • 10. Portal hypertension secondary to azathioprine in myasthenia gravis.
    Fonseca V; Havard CW
    Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?
    Herrlinger U; Weller M; Dichgans J; Melms A
    Ann Neurol; 2000 May; 47(5):682-3. PubMed ID: 10805346
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of myasthenia gravis by immunosuppressive non-steroidal drugs].
    De Assis JL; Marchiori PE; Scaff M; Zambon AA
    Arq Neuropsiquiatr; 1986 Jun; 44(2):109-16. PubMed ID: 3800686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis as a guide for azathioprine therapy in prednisone-resistant myasthenia gravis.
    Rodnitzky RL; Bosch EP
    Muscle Nerve; 1981; 4(6):529-30. PubMed ID: 7311992
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.
    Finsterer J; Frank M; Krexner E
    South Med J; 2010 Feb; 103(2):182-4. PubMed ID: 20065912
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis.
    Matell G
    Ann N Y Acad Sci; 1987; 505():589-94. PubMed ID: 3479940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myelosuppression with macrocytic anaemia and leucopenia during treatment with azathioprine in myasthenia gravis].
    Reinicke H; Weber FW; Hausamen TU
    Dtsch Med Wochenschr; 1982 Oct; 107(42):1592-4. PubMed ID: 7128472
    [No Abstract]   [Full Text] [Related]  

  • 17. Latent carcinoma of the prostate in a 24-year-old man receiving cyclophosphamide and azathioprine.
    Elliott GB; Silverberg DS; Dossetor JB; Muir CS
    Can Med Assoc J; 1977 Mar; 116(6):651-2. PubMed ID: 612349
    [No Abstract]   [Full Text] [Related]  

  • 18. Myasthenia gravis: discontinuation of long-term azathioprine.
    Michels M; Hohlfeld R; Hartung HP; Heininger K; Besinger UA; Toyka KV
    Ann Neurol; 1988 Dec; 24(6):798. PubMed ID: 3207364
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cyclophosphamide in the therapy of myasthenia gravis].
    Smat V; Nouza K
    Cas Lek Cesk; 1970 Sep; 109(44):1030-6. PubMed ID: 5475090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complications of immunosuppresive therapy in chronic nephropathies in children].
    Sasinka M; Plenta I; Pavlovic M; Izakovic V; Kaiserová E; Páleníková O; Stubna J
    Cesk Pediatr; 1976 Mar; 31(3):122-6. PubMed ID: 1269009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.